Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2021-03-11+70,000→ 70,000 totalExercise: $5.30Exp: 2031-03-11→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.